diabetes glp 1 drugs The Rise of GLP-1 Medications – Magnet GLP-1 Drug Savings: A Complete

Description

Will New Oral GLP-1 Agonists Be the Next Market Shaker

First and foremost, our members and customers count on us to be responsible stewards of their health care dollars

doi: 10.1124/dmd.123.001441 [DOI] [PubMed] [Google Scholar] 210.Gouju J, Legeay S

Here's the current landscape: Brand Name Oral Semaglutide (Wegovy pill): Novo Nordisk announced a limited-time price of $149/month for the starting dose Higher doses (25mg) may cost more Launched in January 2026 Additional costs may apply such as labs, consultations, shipping and membership Brand Name Injectable GLP-1s: Wegovy: $1,000-1,500/month without insurance Ozempic: $900-1,000/month without insurance Mounjaro/Zepbound: $1,000-1,400/month without insurance Compounded Injectable GLP-1s: Affinity Whole Health: Starting at $299/month for compounded semaglutide Includes medications, supplies, shipping, and ongoing support Significant savings compared to brand names Compounded ODT Formulations: Prices vary widely, typically $299-449/month for compounded semaglutide or tirzepatide ODTs Generally more expensive than compounded injectables Available through compounding pharmacies Currently, compounded injectable medications from FDA-registered facilities remain the most cost-effective option for most patients seeking GLP-1 therapy